After an incredible week that saw shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) appreciate a surprising 80% on Monday, shares of this biotech took a 10% haircut today. Why the drop? In this video, health care analyst Max Macaluso discusses today's decline and offers his opinion of what investors should watch in the coming weeks.
- Jan 9, 2013 at 2:41PM
- Health Care
- 3 Drug Stocks That Soared This Week: Are They Buys?
- It's the Little Things That Matter for Peregrine Pharmaceuticals
- Peregrine Pharmaceuticals' Stock Sank in September: Is It Now a Buy?
- 5 Things Peregrine Pharmaceuticals Wants You to Know
- This Small-Cap Cancer Immunotherapy Developer Is Gaining Traction